Financial and risk considerations for successful disease management programs.
Results for disease management [DM] programs have not been as positive as hoped because of clinical issues, lack of access to capital, and administrative issues. The financial experience of DM programs can be quite volatile. Financial projections that are protocol-based, rather than experience-based, may understate the revenue required and the range of possible costs for a DM program by understating the impact of complicating conditions and comorbidities. Actuarial tools (risk analysis and risk projection models) support better understanding of DM contracts. In particular, these models can provide the ability to quantify the impact of the factors that drive costs of a contract and the volatility of those costs. This analysis can assist DM companies in setting appropriate revenue and capital targets. Similar analysis by health plans can identify diseases that are good candidates for DM programs and can provide the basis for performance targets.
Baldwin
A L
AL
Milliman & Robertson, Seattle, Wash., USA.
D019985:Benchmarking; D002204:Capitation Fee; D019468:Disease Management; D005376:Financial Management / Q000458:organization & administration*; D008329:Managed Care Programs / Q000191:economics* / Q000458:organization & administration*; D020414:Risk Sharing, Financial / Q000458:organization & administration*